OmniAb, Inc. cotiza a 4.70 USD y tiene una capitalización bursátil de $683M. En los últimos 12 meses ha facturado $38M con un margen de flujo de caja libre del -198.3%. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
OmniAb, Inc., a biotechnology company, licenses discovery research technology to pharmaceutical and biotech companies, and academic institutions to enable the discovery of therapeutics in the United States, Europe, Japan, China, and Canada. The company's technology platform creates and screens diverse antibody repertoi…
| Periodo | 2026-11 | 2026-08 | 2026-05 | 2026-03 |
|---|---|---|---|---|
| Real | — | $-0.05 | $-0.06 | $-0.11 |
| Estimado | $-0.13 | $-0.13 | $-0.10 | $-0.09 |
| Sorpresa | — | +61.5% | +40.0% | -22.2% |
| Métrica | OABI | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | — | 57.0% | — |
| Operating Margin | -369.5% | -38.6% | -330.9% |
| Net Margin | -347.0% | -33.6% | -313.5% |
| FCF Margin | -198.3% | -13.9% | -184.5% |
| ROE | -24.3% | -40.4% | +16.1% |
| ROA | -21.5% | -32.0% | +10.5% |
| Current Ratio | 4.02 | 2.84 | +1.18 |
| Debt / Equity | — | 0.28 | — |